ArticleCancer immunology, immunotherapy : CII2015

Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study.

Katy J McCann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.